Detact Diagnostics B.V.
Detact Diagnostics is dedicated to developing innovative, rapid, and affordable infection detection solutions using their proprietary VIPER® platform technology. Their mission is to revolutionize infection diagnostics globally by providing user-friendly, scalable, and sensitive tests that enable early diagnosis and effective treatment, especially in resource-limited settings.
Industries
Nr. of Employees
small (1-50)
Detact Diagnostics B.V.
Turftorenstraat 14, 9712 BP, Groningen, The Netherlands
Products
Portable NIR fluorometer (handheld point-of-care reader)
A compact, battery-operated device for measuring NIR fluorescence from diagnostic assay tubes or cuvettes to deliver rapid, high-sensitivity readouts at the point of care.
VIPER-based direct pathogen and enzymatic assay platform
A chemistry-based assay platform for direct detection of viable pathogens and enzymatic activities in clinical and industrial samples, designed for rapid results and compatibility with portable readers or plate readers.
Portable NIR fluorometer (handheld point-of-care reader)
A compact, battery-operated device for measuring NIR fluorescence from diagnostic assay tubes or cuvettes to deliver rapid, high-sensitivity readouts at the point of care.
VIPER-based direct pathogen and enzymatic assay platform
A chemistry-based assay platform for direct detection of viable pathogens and enzymatic activities in clinical and industrial samples, designed for rapid results and compatibility with portable readers or plate readers.
Services
Development and optimization of fluorescence-based assays formulated for rapid, no-sample-prep detection and adapted for point-of-care or laboratory workflows.
Development and testing of portable NIR fluorometer prototypes for field and clinical use, including basic QC and data tracking features.
On-site pilot studies, end-user training and iterative feedback collection in clinical or resource-limited environments to validate usability and inform product refinement.
Quality management practices and regulatory alignment for medical device/IVD development consistent with ISO 13485 requirements.
Development and optimization of fluorescence-based assays formulated for rapid, no-sample-prep detection and adapted for point-of-care or laboratory workflows.
Development and testing of portable NIR fluorometer prototypes for field and clinical use, including basic QC and data tracking features.
On-site pilot studies, end-user training and iterative feedback collection in clinical or resource-limited environments to validate usability and inform product refinement.
Quality management practices and regulatory alignment for medical device/IVD development consistent with ISO 13485 requirements.
Expertise Areas
- Point-of-care diagnostic development
- Direct viable-pathogen assay development
- Portable NIR fluorescence instrumentation
- Assay formulation for no-sample-prep workflows
Key Technologies
- Near-infrared (NIR) fluorescence detection
- Direct viable-pathogen fluorescence assays
- Handheld/portable fluorometer hardware
- Reader-agnostic assay formats (POC and plate reader compatibility)
News & Updates
Detact Diagnostics received a $5.9 million USD grant from the Gates Foundation to develop point-of-care diagnostic tests and hardware utilizing VIPER® technology, including the low-cost DeNIRO® mini Fluorometer.
Detact Diagnostics was awarded the first 'Life Science Innovation Award 2022' at the Life Science Conference organized by LifeCooperative, recognizing their groundbreaking VIPER® technology.
Detact Diagnostics received a $5.9M grant from the Gates Foundation to develop diagnostic solutions for infectious diseases, including tuberculosis and syphilis, using VIPER® technology.
The company was recognized for its innovative VIPER® platform technology at the Life Science Conference.
First winner of the Life Science Innovation Award at the Life Science Conference organized by LifeCooperative.
Detact Diagnostics received a $5.9 million USD grant from the Gates Foundation to develop point-of-care diagnostic tests and hardware utilizing VIPER® technology, including the low-cost DeNIRO® mini Fluorometer.
Detact Diagnostics was awarded the first 'Life Science Innovation Award 2022' at the Life Science Conference organized by LifeCooperative, recognizing their groundbreaking VIPER® technology.
Detact Diagnostics received a $5.9M grant from the Gates Foundation to develop diagnostic solutions for infectious diseases, including tuberculosis and syphilis, using VIPER® technology.
The company was recognized for its innovative VIPER® platform technology at the Life Science Conference.
First winner of the Life Science Innovation Award at the Life Science Conference organized by LifeCooperative.